Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

BACKGROUND: To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients. MATERIALS AND METHODS: Endpoints of the analysis were: (a) treatment discontinuation of RPV/FTC/TDF for any reasons and (b) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinnetti, Carmela, Di Giambenedetto, Simona, Maggiolo, Franco, Lorenzini, Patrizia, Fabbiani, Massimiliano, Tommasi, Chiara, Latini, Alessandra, Ammassari, Adriana, Loiacono, Laura, Sterrantino, Gaetana, Bellagamba, Rita, Boumis, Evangelo, Antinori, Andrea, Zaccarelli, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P280
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225448/
https://www.ncbi.nlm.nih.gov/pubmed/25397556
http://dx.doi.org/10.7448/IAS.17.4.19812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225448/
https://www.ncbi.nlm.nih.gov/pubmed/25397556
http://dx.doi.org/10.7448/IAS.17.4.19812

Ejemplares similares